PK Stock Recent News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

JXN, PK, and RGA made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 11, 2024.

The travel and vacation industry is back in full swing. Now, many investors who bought in during the COVID-19 pandemic dip are feeling the excitement of a revived market.

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of the in-clinic portion of its pharmacokinetic (PK) study, a core component of the Company's clinical study plan for its 510(k) pathway for regulatory approval.

Pharmacokinetic study is key step on path to expansion into US market Pharmacokinetic study is key step on path to expansion into US market

TYSONS, Va., June 11, 2024 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (“Park”) (NYSE: PK) today announced that it plans to report financial results for the second quarter 2024 after the stock market closes on Wednesday, July 31, 2024. Park will hold a conference call on Thursday, August 1, 2024, at 12:00 p.m. Eastern Time (ET) to discuss its earnings results, current operational environment and business outlook.

Given its robust fundamental growth and aligned valuation, we maintain our buy rating on Park Hotels & Resorts Inc. PK REIT's latest results show illustrious unitary growth. Moreover, a spread between asset-level returns and liability costs is encouraging. Despite the high cost, a solid development pipeline and unit upgrades could add value.

Park Hotels & Resorts is a hotel REIT, generating a significant portion of its revenue from the Hawaii and Orlando markets. The market outlook is overall positive and the management has guided for a higher range of FFO per share and adjusted EBITDA this year. This is a conservatively financed business with strong liquidity, but more importantly, the dividend appears to be well-covered and the shares undervalued.

While real estate investment trusts aren't the most exciting ideas available, their generally reliable platform makes REIT stocks a compelling avenue for success. That's especially the case amid the uncertainties clouding the present market cycle.

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful recruitment and commencement of screening for subjects in its pharmacokinetic (PK) study, a critical component of the Company's FDA 510(k) regulatory pathway for clearance.